top of page

Representative Publications and Research Links

Publications

  • Dodson, W.W., Modestino, E.J., Titiz-Ceritoğlu, H., & Zayed, B. (2024) Rejection Sensitivity Dysphoria in Attention-Deficit/Hyperactivity Disorder: A Case Series.  Acta Scientific Neurology, 7(8): 23-30. DOI: 10.31080/ASNE.2024.07.0762

  • Modestino, E.J., Bowirrat A, Baron, D., Thanos, P.K., Hanna, C., Bagchi, D., Braverman, E.R., Dennen, C.A., Badgaiyan, R.D., Pollack, A.R., Lewandrowski, K.-U., Sharafshah, A., Gold, M.S., & Blum, K. (2024) Is there a natural, non-addictive, and non-anti-reward, safe, gene-based solution to treat Reward Deficiency Syndrome (RDS)? KB220 variants vs. GLP-1 analogs. J Addict Psychiatry, 8(1): 34-49

  • Modestino, E.J., Bowirrat, A., Lewandowski, K.-U., Sharafshah,  A., Badgaiyan, R.D., Thanos, P.K., Baron, D., Dennen, C.A., Elman, I., Sunder, K., Murphy, K.T., & Blum, K. (2024). Hemiplegic migraines exacerbated using an injectable GLP-1 agonist for weight loss.  Acta Scientific Neurology, 7(5): 12-18.  DOI: 10.31080/ASNE.2024.07.0731

  • Dodson, W.W., & Modestino, E.J. (2024). Have we placed the cart before the horse by using alpha-2A agonists to treat rejection sensitivity dysphoria in ADHD? Current Psychopharmacology, e050424228696.  DOI: 10.2174/0122115560297397240404071044

  • Modestino, E. J., Blum, K., Dennen, C. A., Downs, B. W., Bagchi, D., Llanos-Gomez, L., Elman, I., Baron, D., Thanos, P. K., Badgaiyan, R. D., Braverman, E. R., Gupta, A., Gold, M. S., & Bowirrat, A. (2022). Theorizing the role of dopaminergic polymorphic risk alleles with intermittent explosive disorder (IED), violent/aggressive behavior and addiction: Justification of genetic addiction risk severity (GARS) testing. Journal of Personalized Medicine, 12(12), 1946. https://doi.org/10.3390/jpm12121946 

 

  • Steinberg, B., Carey, E., Modestino, E.J., Lubar, J., Thanos, P.K, Baron, D., & Blum, K. (2019) Pro-dopamine regulation with KB220Z improves working memory in an adult with ADHD—A case report and replication. Open Journal of Clinical & Medical Case Reports. 5(2):1512. https://jclinmedcasereports.com/articles/OJCMCR-1512.pdf

  • Modestino, E.J., Reinhofer, A., Blum, K., Amenechi, C. & O’Toole, P. (2018). Hoehn and Yahr staging of Parkinson’s disease in relation to neuropsychological measures. Frontiers in Bioscience, 23(7), 1370–1379. https://doi.org/10.2741/4649 

 

  • Modestino, E. J., Amenechi, C., Reinhofer, A., & O’Toole, P. (2016). Side‐of‐onset of Parkinson’s disease in relation to neuropsychological measures. Brain and Behavior, 7(1). https://doi.org/10.1002/brb3.590 

 

  • Modestino, E.J., O’Toole, P., & Reinhofer, A. (2016). Experiential and doctrinal religious knowledge categorization in Parkinson’s disease: Behavioral and brain correlates. Frontiers in Human Neuroscience, 10. https://doi.org/10.3389/fnhum.2016.00113 

 

 

 

  • Modestino, E.J., ​& Winchester, J. (2013). A retrospective survey of childhood ADHD symptomatology among Adult Narcoleptics. Journal of Attention Disorders, 17(7), 574-582.  https://doi.org/10.1177/1087054713480033

Dr. Modestino's Doctoral Dissertation

“The Neural Correlates of Endogenously Cued Covert Visuospatial Attentional Shifting in the Cue-Target Interval: An Electroencephalographic Study."

Dr. Modestino’s Scientific Journal Appointments: 

Here are links to Dr. Modestino’s research: ​
OCRID
Here are links to Dr. Modestino’s Facebook Groups: ​

Nick and Danielle are administrators/moderators as Dr. M. does not use Facebook.

bottom of page